Sector revisions Pfizer Inc.

Equities

Market Closed - Nyse Other stock markets 04:00:02 2026-01-16 pm EST			5-day change	1st Jan Change
25.65 ^USD	-0.93%		+0.67%	+3.01%

Jan. 17	American CEOs push back on Trump ... mildly	RE
Jan. 16	Pfizer-backed Agomab Therapeutics reveals wider loss in US IPO filing	RE

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	PFIZER INC.							24
	ELI LILLY AND COMPANY							28
	JOHNSON & JOHNSON							24
	ABBVIE INC.							27
	ROCHE HOLDING AG							19
	ASTRAZENECA PLC							20
	NOVARTIS AG							20
	MERCK & CO., INC.							27
	NOVO NORDISK A/S							21
	AMGEN INC.							27
	GILEAD SCIENCES, INC.							26
	SANOFI							22
	BRISTOL-MYERS SQUIBB COMPANY							23
	VERTEX PHARMACEUTICALS INCORPORATED							25
	GSK PLC							19
	CHUGAI PHARMACEUTICAL CO., LTD.							14
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							17
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	ALNYLAM PHARMACEUTICALS, INC.							25
	Average							22
	Weighted average by Cap.							24